Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Paul Riley will lead the scientific vision of the first institute of its kind in the world to physically merge the disciplines of developmental biology and regenerative medicine in a common goal to treat some of the world’s most prolific diseases.

A profile of Paul Riley, and an image of the IDRM building.
Load More

Similar stories

BBSRC-funded Oxford-Cambridge consortium to close the gap in our understanding of human heart development

A research consortium of DPAG/IDRM and University of Cambridge scientists have been awarded a major strategic grant by the Biotechnology and Biological Sciences Research Council (BBSRC) to answer the pressing long-standing questions of how the human heart grows, how it is put together, and how the different heart cells communicate with each other during pregnancy.